Financial Snapshot
What does DuPont’s latest financial snapshot show?
Mixed. The strongest factor is transaction-adjusted free cash flow of $689M for Full Year 2025, while the main concern is legal or separation-related liabilities and still-material debt.
For Full Year 2025, DuPont de Nemours, Inc. showed a mixed financial picture: sales improved, cash generation was strong, and liquidity looked stable. This verdict combines growth, profitability, cash generation, balance-sheet capacity, and capital efficiency. For mission and strategy context, see Mission Statement, Vision, & Core Values (2026) of DuPont de Nemours, Inc. (DD).
First, deeper analysis should focus on transaction-adjusted free cash flow, since it best shows how DuPont turns earnings into cash.
Revenue Quality
Does DuPont’s revenue growth translate into better earnings quality?
Mixed. DuPont’s $68B full year 2025 net sales and Adjusted EPS was $168 both rose sharply, but the quality signal is uneven because Healthcare & Water Technologies drove stronger organic growth while Diversified Industrials declined.
Revenue growth looks meaningful, but quality depends on whether it is durable and converts into profit. Investors compare sales with operating income, net income, and EPS across the same annual periods because that shows whether growth is broad, repeatable, and supported by real margin improvement rather than temporary volume or mix effects. For background on the company’s structure, see DuPont de Nemours, Inc. (DD): History, Ownership, Mission, How It Works & Makes Money.
| Measure | Latest Period | Previous Period | Quality Test | Investor Meaning |
|---|---|---|---|---|
| Revenue | $68B net sales, 20% increase, Full Year 2025 | Full Year 2024 net sales | Organic and segment-led, with Healthcare & Water Technologies showing 70% organic sales growth | Suggests growth is real, but durability depends on whether the stronger segments keep expanding |
| Operating Income | Q1 2026 FMP operating income of $18600M | Previous comparable period not provided | Latest period confirms earnings generation, but like-for-like comparison is limited | Supports profitability, though the growth-to-margin link is harder to judge from one period alone |
| Net Income | Q1 2026 FMP net income of $16100M | Previous comparable period not provided | Positive final earnings, with no unusual-item detail provided | Confirms that sales are reaching the bottom line |
| Diluted EPS | $039, Q1 2026 FMP | Adjusted EPS was $168 for Full Year 2025 | Per-share results improved faster than sales, though period mismatch limits a strict comparison | Shareholders saw stronger earnings per share performance than revenue alone suggests |
How durable is DuPont’s revenue growth?
The strongest durability signal is Healthcare & Water Technologies, where regulated healthcare, water, and specialty materials demand can create steadier repeat business. The biggest limitation is Diversified Industrials, where a 20% organic sales decline tied to global construction weakness shows cyclicality and mix risk.
- Demand Quality: Regulated healthcare and industrial water support recurring demand visibility; construction-linked industrial demand is more cyclical.
- Pricing and Volume: The split between price, volume, and mix was not fully provided, so the quality read is driven mainly by segment growth and decline patterns.
- Diversification: Growth is more balanced across healthcare, water, and specialty materials, but Diversified Industrials still adds concentration risk through construction exposure.
That mix points to better earnings quality when product vitality stays high and cash conversion follows.
Cash Conversion
Are DuPont de Nemours, Inc. (DD) profits turning into real cash?
Yes, DuPont de Nemours, Inc. (DD) showed stronger earnings and the 2025 cash picture was supportive. Full Year 2025 Transaction-Adjusted Free Cash Flow was $689M, with a 980% conversion rate, which is stronger evidence than earnings alone. Q1 2026 profit remained positive, but exact margin percentages were not supplied.
Gross margin shows product economics, operating margin shows how well DuPont de Nemours, Inc. (DD) controls selling and overhead costs, and net margin shows what is left after interest and taxes. Net income can rise even when cash is delayed, so operating cash flow, capital expenditure, and free cash flow matter for quality of earnings. For a broader strategy lens, Mission Statement, Vision, & Core Values (2026) of DuPont de Nemours, Inc. (DD) can help connect profitability to corporate direction.
| Measure | Latest Period | Previous Period | Verified Driver | Investor Meaning |
|---|---|---|---|---|
| Gross Margin | Unavailable; Q1 2026 gross profit was $60200M on revenue of $168B. | Unavailable | Exact margin percentage was not supplied, so the latest verified profitability input is gross profit, not a confirmed margin rate. | Shows the business remained profitable at the product level, but the exact margin trend cannot be verified from the supplied data. |
| Operating Margin | Unavailable; Q1 2026 operating income was $18600M. | Unavailable | Exact margin percentage was not supplied, so only operating profit is verified. | Suggests operating leverage was positive, but the margin trend cannot be measured precisely here. |
| Net Margin | Unavailable; Q1 2026 net income was $16100M. | Unavailable | Income before tax was $18100M and income tax expense was $3100M, but a verified margin percentage was not supplied. | Final profitability remained positive, yet the exact net margin trend cannot be confirmed from the supplied data. |
| Operating Cash Flow | Unavailable | Unavailable | Only growth data was supplied, including Operating Cash Flow Growth of 22676% at 2026-03-31, not an absolute operating cash flow value. | Cash generation improved sharply, but the underlying cash amount is not verified in the prompt. |
| Free Cash Flow | $689M (Full Year 2025 Transaction-Adjusted Free Cash Flow) | Unavailable | Free cash flow remained positive even after reinvestment needs, and the 980% conversion rate points to strong cash support for earnings. | Leaves room for reinvestment, debt service, and shareholder returns if the conversion holds. |
What most affects DuPont de Nemours, Inc. (DD) cash conversion?
The strongest verified driver is free cash flow conversion, especially the 980% rate in Full Year 2025. That points to earnings translating into cash, while Q1 2026 growth data also shows operating cash flow and free cash flow can move differently.
- Main Driver: Strong transaction-adjusted free cash flow conversion looks structural for now, but reinvestment and working capital can still swing results.
- Evidence Gap: The prompt does not provide full-year operating cash flow or capital expenditure amounts.
- Metric to Monitor: Track transaction-adjusted free cash flow and operating cash flow growth together.
Post-Divestiture Liquidity
Can DuPont de Nemours, Inc. fund itself safely after divestitures?
Mixed. DuPont de Nemours, Inc. has solid near-term liquidity, but its balance sheet still carries a heavy debt load relative to cash. The main protection is $75.2M cash and $5.64B current assets, while the main financing concern is that reported debt exceeds cash and intangible asset concentration is high.
Cash alone does not tell the full story. DuPont de Nemours, Inc. also needs enough working capital, asset quality, debt service capacity, solvency, liquidity, and refinancing access to keep funding operations and investment after divestitures. The latest figures point to decent short-term coverage, but leverage and intangibles still deserve close monitoring.
| Area | Latest Evidence | Assessment | Investor Meaning |
|---|---|---|---|
| Cash and Working Capital | $75.2M cash and cash equivalents at 2026-03-31; total current assets of $5.64B against total current liabilities of $2.10B; net working capital of $17B at 2025-12-31. | Strong | Near-term obligations look manageable without forcing an immediate cut in investment. |
| Total and Net Debt | Add Total Debt of $31.9B at 2025-12-31 and $31.7B at 2026-03-31; short term debt of $4,000M and long term debt of $31.3B. | Weak | Leverage is high and leaves less room for mistakes if operating results weaken. |
| Debt Service and Refinancing | Annual interest expense was $313M in 2025, down from $366M in 2024. | Mixed | Interest burden is lower, but debt remains large enough that access to funding still matters. |
| Asset Quality | Total assets of $214.5B at 2026-03-31; goodwill of $78.7B, intangible assets of $28.6B, and goodwill and intangible assets of $107.3B. | Weak | High intangible concentration raises impairment risk and makes book value less durable. |
| Liabilities and Equity | Total liabilities are not fully listed in the supplied data, but reported debt is well above cash and the asset base includes substantial goodwill and intangibles. | Mixed | The equity cushion can absorb some pressure, but the capital structure is still debt-heavy. |
Which balance-sheet risk matters most for DuPont de Nemours, Inc.?
Debt load matters most. Reported debt of $31.7B at 2026-03-31 far exceeds cash of $75.2M, while goodwill and intangibles total $107.3B, making leverage and asset-quality risk the main focus.
- Current Exposure: Debt of $31.7B versus cash of $75.2M at 2026-03-31.
- Protection: Total current assets of $5.64B against total current liabilities of $2.10B.
- Warning Signal: Monitor whether debt stays high while goodwill and intangible assets remain near $107.3B.
If you’re using this topic for a paper or case study, a structured SWOT Analysis, PESTLE Analysis, or Business Model Canvas can help you organize the research into clear arguments. Exploring DuPont de Nemours, Inc. (DD) Investor Profile: Who's Buying and Why?
Capital efficiency
Are DuPont de Nemours, Inc. reinvestment choices creating efficient returns?
Mixed. Internal cash appears sufficient for reinvestment needs, but the return picture is only partly visible because verified ROIC, ROE, and ROA inputs were not supplied. Mission Statement, Vision, & Core Values (2026) of DuPont de Nemours, Inc. (DD) can help frame how those capital choices fit the business strategy.
Return measures should be read alongside leverage, asset intensity, capital expenditures, working capital swings, and any need for outside funding. For DuPont de Nemours, Inc., capital efficiency is as much about how it allocates cash across R&D, M&A, dividends, and buybacks as it is about the headline return ratio.
| Capital Measure | Latest Evidence | Quality Test | Investor Meaning |
|---|---|---|---|
| ROIC | Unavailable in the supplied data. | Cannot be verified without a reported ROIC; DuPont de Nemours, Inc. still shows cash generation and post-separation capital actions that need to earn above the cost of capital. | Investors should look for evidence that invested capital is creating operating value, not just returning cash. |
| ROE and ROA | Unavailable in the supplied data. | ROE would be affected by leverage, while ROA would depend on how efficiently DuPont de Nemours, Inc. uses its asset base. | Shareholder return quality cannot be judged from leverage alone, and asset efficiency still matters. |
| Maintenance and Growth Investment | $47.00M Q1 2026 Research And Development Expenses; $175B Donatelle Plastics acquisition; over 125 new products generating more than $2B in sales in 2025. | R&D and product launches support growth, while the acquisition shows external expansion; maintenance spending was not separately identified. | DuPont de Nemours, Inc. appears to be funding innovation and portfolio expansion, but investors should judge whether those bets lift long-run returns. |
| Internal Funding Capacity | Full Year 2025 Transaction-Adjusted Free Cash Flow was $689M with 98.0% conversion; the quarterly dividend was $0.20 per share; a new $2B buyback was authorized on November 06, 2025, including a $500M accelerated repurchase in Q4 2025; the Aramids sale closed on April 01, 2026 for $1.2B in cash, a $300M note, and a $325M minority equity interest. | Internal funding looks strong because cash flow, asset sales, and buybacks/dividends all point to available capital, though the repurchase and acquisition program still need to be matched against ongoing cash generation. | Investment appears partly internally funded, with added flexibility from divestiture proceeds and continued discipline needed to avoid overextending capital. |
Are DuPont de Nemours, Inc. returns on capital sustainable?
Probably, because R&D-driven product growth and strong free cash flow support durability. The main weakening risk is heavier buybacks, dividends, or acquisitions outpacing transaction-adjusted free cash flow and reducing reinvestment flexibility.
- Operating Source: Over 125 new products and more than $2B in 2025 sales support the cash engine.
- Funding Requirement: The largest verified capital needs are the $2B repurchase program and the $175B Donatelle Plastics acquisition.
- Durability Test: Returns would weaken if free cash flow falls below dividend, buyback, and growth-investment needs, or if R&D stops converting into product sales.
Financial Resilience
How resilient is DuPont de Nemours, Inc. and which warning signs matter most?
Resilience is Mixed. The main buffer is $0.7B cash plus $1.7B net working capital and strong Full Year 2025 cash conversion. The most important warning sign is PFAS liability, because settlement structures exist but ongoing cost-sharing and tax indemnity uncertainties can still pressure cash.
DuPont’s ability to protect liquidity depends on whether cash conversion stays strong while legal payments and operating weakness stay contained. The company also has to keep funding essential investment even if construction markets remain soft, trade-related costs persist, or separation-related timing shifts create short-term volatility. For context, Exploring DuPont de Nemours, Inc. (DD) Investor Profile: Who's Buying and Why? helps frame the equity story.
| Pressure | Financial Effect | Existing Protection | Warning Signal |
|---|---|---|---|
| Revenue or Margin Pressure | PFAS costs, a $20M estimated trade-tariff headwind, and a $30M water-segment order-timing headwind can cut operating leverage, earnings, cash flow, and debt capacity if weakness broadens. | Settlement structures, cost-sharing arrangements, and diversified industrial exposure help soften the hit, while Full Year 2025 cash conversion stayed strong. | Watch for declining segment organic growth, weaker margins, and lower operating cash flow, especially if construction weakness deepens beyond the 20% organic sales decline in Diversified Industrials. |
| Working-Capital or Investment Pressure | PFAS payments, separation execution, receivables, inventory, and capex could absorb cash and reduce room for reinvestment. | $0.7B cash, $1.7B net working capital, and internal cash generation provide near-term flexibility. | Monitor free cash flow conversion, cash balance, PFAS cash payments, and any rise in working-capital needs or capex that outpaces operating cash flow. |
| Interest or Refinancing Pressure | Higher interest or refinancing costs would reduce free cash flow and narrow flexibility for legal spending and strategic investment. | Lower 2025 interest expense and available cash reduce immediate strain. | Watch debt maturity timing, interest expense, and liquidity trends if financing conditions tighten or cash falls faster than expected. |
Which financial warning signs should investors monitor at DuPont de Nemours, Inc.?
PFAS cash payments and free cash flow conversion are the two strongest signals, followed by segment organic growth. PFAS is the confirmed overhang; construction weakness and separation timing are near-term risks that could worsen cash generation if they spread.
PFAS Liability Cash Outflow
The $875M New Jersey settlement, the $27M Hoosick Falls process, and 15,240 AFFF MDL cases in June 2026 show the scale of exposure. Cost-sharing helps, but the next metric is actual PFAS cash payments versus reserved or shared amounts.
Industrial Demand Weakness
Diversified Industrials had a 20% organic sales decline in Full Year 2025 tied to global construction weakness. That hurts operating leverage and cash generation, so investors should watch segment organic growth and margin recovery.
Separation and Timing Disruption
Q4 2025 included a $30M headwind from order timing shifts in the water segment related to separation activities. The issue matters because it can distort revenue and cash flow, so the next metric is segment order flow and delivery timing.
Mixed Check
What does DuPont financial health mean for investors?
DuPont is a Mixed financial-health case. The strongest factor is free cash flow conversion, while the weakest is legal and separation-related cash uncertainty. The most important investment condition is whether self-funded specialty materials growth can outlast litigation, cyclicality, and divestiture complexity.
| Financial Factor | Rating | Evidence and Investor Meaning |
|---|---|---|
| Revenue and Earnings Quality | Mixed | Full Year 2025 Net Sales rose 20% and Adjusted EPS rose 160%, but Diversified Industrials declined 20% organically, so growth is improving but not evenly durable. |
| Profitability and Cash | Strong | Transaction-Adjusted Free Cash Flow was $689M with 980% conversion, and Full Year 2025 Operating EBITDA was $163B, pointing to strong cash generation. |
| Balance Sheet and Liquidity | Mixed | Cash was $0.7B and Net Working Capital was $1.7B at December 31, 2025, while FMP Add Total Debt was $3.17B at 2026-03-31, so flexibility is adequate but not bulky. |
| Capital Efficiency | Mixed | Buybacks, dividends, R&D, and portfolio actions can support per-share value, but verified ROIC, ROE, and ROA are not supplied, limiting a full efficiency read. |
| Financial Resilience | Mixed | Cash conversion and lower interest expense help, but PFAS, tax indemnity, tariffs, construction weakness, and separation timing create pressure points. |
- What Supports the Thesis: Strong cash conversion, improving earnings, and self-funded specialty materials growth.
- What Challenges the Thesis: Legal exposure, cyclicality, and divestiture complexity may reduce future financial flexibility.
- What to Monitor: Transaction-Adjusted Free Cash Flow conversion rate, Cash and Cash Equivalents, Annual Interest Expense.
For company background that helps frame the numbers, see DuPont de Nemours, Inc. (DD): History, Ownership, Mission, How It Works & Makes Money; the financial case will still depend on how forecasts and scenarios translate cash generation and litigation risk into valuation.
FAQ
What Do Investors Ask About 's Financial Health?
Investors most often ask about the company's revenue quality, profitability, cash generation, debt, liquidity, capital efficiency, and ability to withstand financial pressure.
How much cash did DuPont hold at year-end?
DuPont reported Total Cash and Cash Equivalents of $07B as of December 31, 2025 FMP also shows Minus Cash And Cash Equivalents of $75700M at 2025-12-31 and Cash And Cash Equivalents of $75200M at 2026-03-31
Why did DuPont 2025 interest expense fall?
Annual Interest Expense for 2025 was $313M, down from $366M in 2024 The data supports a lower interest burden, but no supplied source gives specific causes such as refinancing, maturities, coupon changes, or debt repayment timing
How could PFAS claims affect DuPont liquidity?
PFAS claims can affect liquidity through settlement payments, cost-sharing liabilities, and timing uncertainty Relevant items include the $875M New Jersey settlement involving DuPont, Chemours, and Corteva, the $27M Hoosick Falls settlement process, and 15,240 AFFF MDL cases in June 2026
What supports DuPont capital efficiency after divestitures?
Capital efficiency is supported by strong cash conversion, portfolio reshaping, product vitality, and disciplined capital returns DuPont generated $689M of Transaction-Adjusted Free Cash Flow in Full Year 2025 and authorized a $2B share repurchase program, but verified ROIC, ROE, and ROA were not supplied
Can DuPont fund dividends and buybacks internally?
DuPont’s Full Year 2025 Transaction-Adjusted Free Cash Flow of $689M and 980% conversion rate support internal funding capacity The company also set a $020 per share quarterly dividend and a 35% to 45% payout ratio target, but PFAS costs and reinvestment needs remain monitoring items